Rhythm remains a high-quality, high-growth medtech company with strong GM and revenue momentum, but capital intensity ...

Glaukos posts 30% revenue growth and pipeline expansion but faces regulatory and valuation risks. Read more on why I ...

Current risk analysis methods focus on the possibility and severity of bad events instead of focusing directly on analyzing ...

The new plant will not only replicate these existing product lines but also introduce radiology (X-ray, CT, MRI) and oncology-focused devices (biopsy systems, oncology-specific infusion units) GREATER ...

Alphabet's Verily was one of the company's star "moonshot" businesses, with its research delving into areas ranging from connected diabetes therapies to robot surgery. Now, Verily has shuttered its ...

A Nothing Phone 3 retail demo was spotted making misleading claims about photo samples. Android Authority has spoken to two of the photographers who shot the pics, who confirm they did not use the ...

The costs associated with the ‘Trump tariffs’ will be passed onto the US customers of US medical device firm, Cook Medical where possible. That is according to the directors at one of the largest ...

Hillary Clinton was also in tow with the former president, who suffered a heart attack that required bypass surgery in 2004. News Reporter Former President Bill Clinton was spotted at the airport on ...

New Delhi: As part of its latest rate rationalisation exercise, the GST Council has announced a steep cut in levies on medical devices. Finance Minister Nirmala Sitharaman on Wednesday outlined that ...

In early September 2025, numerous social media posts online speculated about U.S. President Donald Trump's health, particularly after photographs claiming to show mysterious bumps under his suit ...

One of Canada’s most promising life-sciences companies, Kardium Inc., has received regulatory approval to take its medical device to market in the United States. Kardium, developer of a device to ...

Alphabet’s life sciences arm Verily laid off staff and eliminated its entire devices program Monday. CEO Stephen Gillett announced the “difficult decision” to wind down the program in a staff memo, ...